Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 3,200 shares, an increase of 18.5% from the March 15th total of 2,700 shares. Approximately 0.0% of the company's stock are sold short. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 32.0 days.
Analysts Set New Price Targets
Separately, DZ Bank raised Sartorius Aktiengesellschaft from a "strong sell" rating to a "hold" rating in a research report on Thursday, April 17th.
Get Our Latest Analysis on Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft Stock Performance
Sartorius Aktiengesellschaft stock remained flat at $212.00 during trading hours on Friday. Sartorius Aktiengesellschaft has a one year low of $165.00 and a one year high of $252.54. The stock has a market cap of $7.26 billion, a P/E ratio of 160.61 and a beta of 1.24. The business's fifty day simple moving average is $186.87 and its 200 day simple moving average is $196.93. The company has a quick ratio of 1.13, a current ratio of 2.02 and a debt-to-equity ratio of 1.17.
Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) last posted its quarterly earnings data on Wednesday, April 16th. The company reported $1.28 EPS for the quarter, meeting the consensus estimate of $1.28. The business had revenue of $959.23 million for the quarter, compared to the consensus estimate of $867.08 million. Sartorius Aktiengesellschaft had a return on equity of 7.33% and a net margin of 2.48%.
Sartorius Aktiengesellschaft Company Profile
(
Get Free Report)
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.
Featured Stories
Before you consider Sartorius Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sartorius Aktiengesellschaft wasn't on the list.
While Sartorius Aktiengesellschaft currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.